Is It Time to Reconsider the Role of Patient Co-Payments for Pharmaceuticals in Europe?

European Journal of Health Economics - Germany
doi 10.1007/s10198-011-0353-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pain Management: Is It the Time to Reconsider Using Opioids?

Journal of Pain Management & Medicine
2015English

Constipation in Chronic Kidney Disease: It Is Time to Reconsider

Renal Replacement Therapy
2019English

Never Use Anthracyclines With Trastuzumab: It Is Time to Reconsider the Taboo

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Is It Time to Reconsider Combination Lipid Therapy in High-Risk Diabetic Patients?

Current Opinion in Lipidology
NutritionGeneticsCell BiologyMolecular BiologyCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2016English

Editorial: Risk Factors for Persistent Villus Atrophy in Coeliac Disease - Is It Time to Reconsider Definitions for Refractory Coeliac Disease?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Is It Time for Prosthesis–patient Mismatch Paradox?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Trends in Time to Market Access in Europe - Is It Getting Better?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Editorial: Risk Factors for Persistent Villus Atrophy in Coeliac Disease - Is It Time to Reconsider Definitions for Refractory Coeliac Disease? Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Primaquine for All: Is It Time to Simplify Malaria Treatment in Co-Endemic Areas?

The Lancet Infectious Diseases
Infectious Diseases
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy